Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 33 for “"beta-blocker"”.
-
Beta-blocker therapy in the era of primary percutaneous intervention for ST elevation myocardial infarction
BACKGROUND: The potential benefit of beta-blocker for ST-elevation myocardial infarction (STEMI) was believed as therapeutic effects of left ventricular (LV) dysfunction. With present therapeutic advance, numbers of STEMI patients with LV dysfunction have been decreased. We studied the long term …
-
Quantifying the Risk of Beta-Blockers and Non-Steroidal Anti-Inflammatory Drugs in Asthma
Beta-blockers and non-steroidal anti-inflammatory drugs (NSAIDs) are often avoided in asthma over risk of bronchospasm which may vary according to drug selectivity and duration of administration. This thesis attempts to quantify the risk of beta-blocker and NSAID exposure in asthma by synthesising …
-
The Effectiveness of Beta-blockers after Myocardial Infarction in Patients with Type 2 Diabetes
Beta-blocker therapy reduces mortality and reinfarction after myocardial infarction (MI), but randomized triais have not included subjects with diabetes as a primary subgroup of interest. A retrospective cohort study was conducted using the Saskatchewan Health Databases to determine the effects of …
-
A Study of the Action of Prostaglandin F2a on the Guinea-Pig Isolated Trachea
… was placed on considerations of the possible beta-adrenergic blocking activities of this essential fatty-acid derivative. | Experiments were performed using a 20 ml tissue bath and a modified phosphate-Tyrode solution. Measurements were made by an isotonic myograph and displayed on a …
-
The Ventilatory Threshold and Maximal Steady-State Exercise in Patients with Coronary Artery Disease
… (MI+, N=20; MI-, N=11) and administration of beta-blocker medications (BB+, N=16; BB-, N=15). RESULTS: Overall, subjects demonstrated significantly more MSS+ responses than MSS- responses (80% Vs 20%, P<0.05). Analysis of the subgroup data showed that it was the patient s with a history of MI …
-
The effects of coronary heart disease, beta-blockade medications and stage duration on graded exercise testing
Controversy exists regarding the effects of beta-blocker medications on functional capacity in cardiac patients and in the effects of disease-related impairments on cardiorespiratory dynamics during exercise testing. Therefore, this study was conducted to examine the exercise responses of 26 …
-
Correlation of Homocysteine Concentration with Plasma Fibrinogen and Physical Activity in Males with Coronary Artery Disease
… Univariate analyses revealed those subjects on beta-blocker therapy (n = 12) had lower fibrinogen concentrations than those not on these medications (n = 28) (277.7 ± 16.7 vs. 316.1 ± 10.9 mg/dl , respectively, p = 0.04). A trend existed for those on beta-blockade to also have lower Hcy …
-
Kardioprotektion durch Veränderung des Zytoskelettes im Langendorff-Hypoxie-Modell der Ratte
… properties of the myocytes. Carvedilol is a beta blocker with alpha-receptor blocking quality and, in addition, antioxidative and antiapoptotic properties. As a comparison are used the beta blocker Propranolol and the Carvedilol analogon BM 91.0228, which owns in comparison to the mother's …
-
Adherence to medication in patients with heart failure : effect on mortality and hospitalization
… increases the risk for death and disability. Beta blockers and ACE inhibitors have become standard treatments in heart failure because clinical trials have demonstrated their beneficial effect on mortality and morbidity in these patients. As not much is known about adherence to these …
-
Factors Associated With the Provision of Coronary Heart Disease Preventive CareServices
… The secondary preventive measures include beta-blocker reciept after myocardial infarction (MI) and statin drug use for the treatment of high blood cholesterol.Being uninsured is associated with a reduced likelihood of receiving primary CHD preventive care. Overall study results indicated …
-
Leitlinienadhärenz hausärztlicher Pharmakotherapie der chronischen Herzinsuffizienz
… ACE-Hemmer (75% vs. 58%; Sχ2=6,474, p=0,011), Beta-Blocker (89% vs. 50%; Sχ2=28,800, p<0,001) und Diuretika (90% vs. 68%; Sχ2=6,129, p<0,001) ein als Patienten der Kontrollgruppe. Nach Ablauf eines Jahres konnten bei konstanten Verschreibungszahlen in der Kontrollgruppe weiterhin signifikante …
-
Military Sexual Trauma Exposure and Heart Rate Variability Outcomes in Female Veterans
… (DM), and tobacco use but improvement with beta blocker (BB) treatment. No prior study evaluated the relationship between military sexual trauma (MST) exposure and HRV outcomes. The hypothesis of this study was that female veterans exposed to MST would have lower time domain HRV measures …
-
Commonly used medications and survival from ovarian cancer
… converting enzyme inhibitors (ACEIs), beta blockers (BBs), calcium channel blockers (CCBs) and thiazide diuretics (TDs)]) was defined as two or more fills for a given medication class during the year after diagnosis. Ovarian cancer-specific death was assessed starting one year after …
-
Evidenz-basierte Pharmakotherapie der Herzinsuffizienz an der stationär-ambulanten Schnittstelle
… mehr ACE- Hemmer (54,9% vs. 72,5%) und Beta-Blocker mit erwiesenem Langzeiteffekt (Metoprolol, Bisoprolol, Carvedilol, 64,3% vs. 89.0%). Auch Aldosteronantagonisten wurden in der Klinik häufiger verabreicht als nach Entlassung (38,5% vs. 33,8%). Die Verordnung der Aldosteronantagonisten …
-
Die Bedeutung des löslichen (Pro)Reninrezeptors als Biomarker für Patienten mit Herzinsuffizienz
… flussen (ACE-Hemmer p=0,01, Angiotensinrezeptorblocker p=0,42 und Aldosteron- Antagonisten p=0,13), als auch mit Beta-Blocker (p=0,005) und Diuretika (p=0,02), zeigten höhere sPRR- Plasmakonzentrationen im Vergleich zu Patienten ohne diesen Medikamenten in der Herzinsuffizienztherapie …
-
Advanced Applications of Cardiac Computed Tomography for the Difficult-to-Image Patient
… safety of an aggressive approach to intravenous beta-blocker use prior to coronary imaging, and the development of patient information to address anxiety as a source of tachycardia and motion artefact. Finally, the novel application of a single source, dual energy CT scanner to additional cardiac …
-
Funktionelle Bedeutung der Nukleosid Diphosphat Kinase für die G Protein-vermittelte Signaltransduktion des Herzens unter Berücksichtigung pathogener Veränderungen bei der Herzinsuffizienz
… Bei Herzinsuffizienz-Patienten , die mit einem beta-Blocker behandelt wurden, war die sarkolemmale NDPK kaum erhöht. Die NDPK-abhängige AC-Aktivität war in diesen Herzen vergleichbar mit gesunden Kontrollen, obwohl auch hier der Gehalt der inhibitorischen G-Proteine erhöht war. Im Tierversuch …
-
Importance of cardiac reserve for evaluation and prediction of cardiac function and morbidity assessed by low-dose dobutamine stress echocardiography
… can predict left ventricular recovery during beta-blocker treatment and that β1AR polymorphism affects cardiac reserve in humans. Cardiac reserve decreases with age and is impaired both in severe heart disease and during progression of myocardial dysfunction in rats. Furthermore, cardiac …
-
Propranolol Elicits Long Term Systemic Effects After Repetitive Mild Traumatic Brain Injury
… immune alterations after injury by injecting the beta blocker propranolol directly after injury and investigating the immune changes in the blood, brain, spleen, and bone marrow of mTBI animals. Together, these data show mTBI causes immune genetic and pathway level changes at least one month after …
Page 1 of 2